Financhill
Back

Beam Therapeutics Quote, Financials, Valuation and Earnings

New AI Stock Payouts

Watch this presentation before then!
Buy
57

BEAM
Beam Therapeutics

Last Price:
39.83
Seasonality Move:
-26.93%

7 Day Trial

ALL ACCESS PASS

$ 7

The "Scaled Selling Technique"

Click here for more details...

Beam Therapeutics Price Quote

$39.83
+0.34 (+0.86%)
(Updated: March 1, 2024 at 5:55 PM ET)

Beam Therapeutics Key Stats

Buy
57
Beam Therapeutics (BEAM) is a Buy

Day range:
$38.92 - $45.05
52-week range:
$16.95 - $49.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.06
P/B ratio:
3.29%

Volume:
2.1M
Avg. volume:
1.7M
1-year change:
-1.86%
Market cap:
$3.2B
Revenue:
$377.7M
EPS:
$-1.9

How Much Does Beam Therapeutics Make?

Is Beam Therapeutics Growing As A Company?

  • What Is Beam Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 14.78%
  • What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Beam Therapeutics Stock Price Performance

What Is Beam Therapeutics 52-Week High & Low?

Beam Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Beam Therapeutics?

  • How Much Debt Does Beam Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Beam Therapeutics Have?
    Cash and short term investments quarterly total is $1.2B
  • What Is Beam Therapeutics’s Book Value Per Share?
    Book value per share is 12.02

Is Beam Therapeutics Cash Flow Positive?

  • What Is BEAM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$149.2M
  • What Is Beam Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $276.4M
  • What Is Beam Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $71.8M

Beam Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BEAM return on invested capital is -16.29%
  • What Is Beam Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -9.78%
  • What Is BEAM Return On Equity?
    ROE is a measure of profitability and is -16.29%

Beam Therapeutics Earnings Date & Stock Price

Beam Therapeutics Competitors

Beam Therapeutics Dividend Yield

Data Unavailable

Beam Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 343.61%
Revenue: 1478.04% 839.01%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 48.38
Upside from Last Price: 22.52%

Major Shareholders

  • How many BEAM shares are owned by institutional investors?
    98.5M BEAM shares are owned by institutional investors
  • How many BEAM shares are owned by insiders?
    1.5M BEAM shares are owned by insiders